H. Phillip Koeffler

H. Phillip Koeffler's AcademicInfluence.com Rankings

H. Phillip Koeffler

Philosophy

#3124

World Rank

#5120

Historical Rank

Logic

#964

World Rank

#1564

Historical Rank

philosophy Degrees

H. Phillip Koeffler

Biology

#3807

World Rank

#5767

Historical Rank

Biochemistry

#378

World Rank

#451

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is H. Phillip Koeffler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

H. Phillip Koeffler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Frequent pathway mutations of splicing machinery in myelodysplasia (2011) (1799)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes (2013) (1219)
The role of the vitamin D endocrine system in health and disease. (1989) (1059)
Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 (2005) (1059)
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. (1998) (883)
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. (1993) (671)
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. (1998) (641)
Molecular Cloning of Transferrin Receptor 2 (1999) (631)
Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. (1978) (529)
Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factor (1986) (487)
Rearrangement of the p53 gene in human osteogenic sarcomas. (1987) (477)
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications (1983) (467)
Role of the cyclin-dependent kinase inhibitors in the development of cancer. (1995) (458)
Absence of WAF1 mutations in a variety of human malignancies. (1994) (439)
1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells (1984) (435)
Human myeloid leukemia cell lines: a review. (1980) (383)
Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells (2004) (335)
Peroxisome proliferator-activated receptor γ and cancers (2003) (328)
P53 mutations in human cancer. (1993) (327)
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms (2012) (325)
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. (1996) (324)
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. (1987) (314)
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. (2002) (309)
Differentiation therapy of leukemia: 3 decades of development. (2009) (300)
p53 in hematologic malignancies. (1994) (298)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). (2012) (285)
An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). (1980) (278)
Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation. (2002) (274)
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. (2007) (264)
1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. (1985) (259)
Tumor suppressor genes in normal and malignant hematopoiesis (2002) (256)
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. (2007) (255)
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk (2010) (253)
Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis (2002) (251)
Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. (1984) (246)
Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells (2004) (246)
Transferrin Receptor 2-α Supports Cell Growth Both in Iron-chelated Cultured Cells and in Vivo * (2000) (243)
gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. (1985) (236)
Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. (1996) (232)
Human p53 gene localized to short arm of chromosome 17 (1986) (227)
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. (2002) (226)
Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. (2007) (222)
Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. (1982) (219)
Frequency and structure of p53 rearrangements in human osteosarcoma. (1990) (213)
Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study (2002) (209)
Mutations of the p53 gene in adult T-cell leukemia. (1992) (206)
20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. (1995) (201)
15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. (2006) (200)
BCL6 enables Ph+ acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition (2011) (200)
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. (1999) (199)
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. (2001) (196)
Recombinant human TNF alpha stimulates production of granulocyte colony- stimulating factor (1987) (196)
Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. (1997) (194)
N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. (1993) (194)
Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. (1999) (190)
Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. (1982) (189)
p53 mutations in human lung tumors. (1992) (185)
Peroxisome proliferator-activated receptor gamma and cancers. (2003) (183)
Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. (1995) (182)
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. (1996) (182)
Cyr61 Is Overexpressed in Gliomas and Involved in Integrin-Linked Kinase-Mediated Akt and β-Catenin-TCF/Lef Signaling Pathways (2004) (180)
A Novel, Myeloid Transcription Factor, C/EBPε, Is Upregulated During Granulocytic, But Not Monocytic, Differentiation (1997) (178)
Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. (1987) (177)
Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. (1991) (175)
Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. (1997) (175)
Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. (1981) (173)
p27/Kip1 mutation found in breast cancer. (1996) (172)
1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. (1990) (166)
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma (2007) (161)
Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. (2003) (158)
Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. (1998) (157)
Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. (2005) (156)
Metabolic gatekeeper function of B-lymphoid transcription factors (2016) (154)
Regulation of expression of murine transferrin receptor 2. (2001) (154)
Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways (2005) (152)
Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells. (1993) (152)
Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. (1997) (151)
A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions. (2000) (150)
Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. (2000) (149)
Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies. (2001) (145)
Cellular Internalization of Insulin-like Growth Factor Binding Protein-3 (2004) (144)
Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor (1997) (141)
Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. (1987) (141)
Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. (2001) (140)
Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. (1994) (140)
Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species. (1987) (140)
Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization. (1989) (140)
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. (1983) (139)
Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. (2009) (139)
Functions of Cyclin A1 in the Cell Cycle and Its Interactions with Transcription Factor E2F-1 and the Rb Family of Proteins (1999) (137)
Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia. (2003) (136)
Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBPε and PU.1 (2003) (136)
Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. (2001) (135)
Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas (2003) (133)
Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein--epsilon. (2001) (131)
Retinoic acid enhances growth of human early erythroid progenitor cells in vitro. (1982) (130)
Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung Cancer* (2001) (130)
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. (1995) (129)
25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. (1987) (129)
Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. (1995) (128)
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia (2007) (128)
Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders. (1988) (128)
Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines. (2007) (127)
Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. (1997) (125)
BCL6 is critical for the development of a diverse primary B cell repertoire (2009) (125)
Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. (1996) (125)
Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents (1988) (124)
Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. (2001) (123)
Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates (2009) (123)
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. (2009) (121)
Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through β-Catenin-T-cell Factor/Lef Signaling* (2007) (121)
Alterations of the p53, Rb and MDM2 genes in osteosarcoma. (1996) (119)
The anti-proliferative effects of 1α,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression (2000) (118)
A potential transcriptional activation element in the p53 protein. (1990) (118)
Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. (1998) (115)
Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. (1997) (114)
Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors (2002) (113)
Characterization of a novel HTLV-infected cell line. (1984) (113)
Mutations in the mitotic check point gene, MAD1L1, in human cancers (2001) (112)
Alterations of the p15, p16,and p18 genes in osteosarcoma. (1996) (112)
Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. (1987) (111)
Regulation of gene expression of myeloperoxidase during myeloid differentiation (1988) (110)
Carcinoma of the vulva: HPV and p53 mutations. (1994) (110)
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. (2004) (108)
Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. (2006) (107)
Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. (2001) (107)
CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. (2003) (107)
The Cyclin A1-CDK2 Complex Regulates DNA Double-Strand Break Repair (2004) (107)
The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling (2006) (106)
N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. (1990) (105)
High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray (2009) (105)
Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. (1993) (105)
Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. (2007) (104)
Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia. (1980) (104)
Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-potent Neutrophil Progenitor. (2020) (102)
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint (2013) (102)
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells. (2007) (102)
Myeloperoxidase: Its Structure and Expression During Myeloid Differentiation (1985) (101)
Erythropoietin radioimmunoassay in evaluating patients with polycythemia. (1981) (101)
Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. (1996) (100)
Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor C/EBPϵ (2002) (99)
1α, 25-(OH)2-D3 and its synthetic analogue decrease tumor load in the Apcmin mouse (2002) (98)
Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. (1997) (98)
Breast Cancer (2001) (98)
Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. (1991) (97)
Allelotype analysis of childhood acute lymphoblastic leukemia. (1995) (97)
Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-alpha and retinoid X receptor-alpha RNA by HL-60 cells. (1993) (96)
Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells (2005) (96)
Vitamin D3 analogs and their 24‐Oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects (1997) (96)
A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. (1997) (96)
A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. (1996) (95)
Mutational effects on the p16INK4a tumor suppressor protein. (1995) (95)
Expression of C/EBPbeta from the C/ebpalpha gene locus is sufficient for normal hematopoiesis in vivo. (2002) (95)
Molecular mechanisms of cancer. (1991) (94)
Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation (2005) (93)
Cyclin A1 expression in leukemia and normal hematopoietic cells. (1999) (92)
Id2 expression increases with differentiation of human myeloid cells. (1996) (91)
p53 mutations in HPV-negative cervical carcinoma. (1994) (90)
Structure-Function Studies on Analogues of 1α,25-Dihydroxyvitamin D3: Differential Effects on Leukemic Cell Growth, Differentiation, and Intestinal Calcium Absorption (1990) (89)
Molecular allelokaryotyping of early‐stage, untreated chronic lymphocytic leukemia (2008) (89)
HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2. (2004) (89)
1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1). (1999) (89)
Dlk1 in normal and abnormal hematopoiesis (2005) (88)
Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. (2000) (88)
5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. (1999) (88)
Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. (1996) (85)
MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells. (2008) (85)
9-cis-retinoic acid : effects on normal and leukemic hematopoiesis in vitro (1993) (84)
Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. (1998) (84)
Polycythemia: mechanisms and management. (1981) (84)
C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. (1999) (83)
Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). (1997) (83)
Increased expression of p53 protein in human leukemia cells. (1986) (83)
Comparative Analysis of Genes Regulated by PML/RARα and PLZF/RARα in Response to Retinoic Acid Using Oligonucleotide Arrays (2003) (82)
Myeloid Transcription Factor C/EBPɛ Is Involved in the Positive Regulation of Lactoferrin Gene Expression in Neutrophils (1999) (82)
Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation. (1991) (82)
A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies (2009) (82)
Myeloperoxidase: its structure and expression during myeloid differentiation. (1985) (82)
Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. (2001) (81)
Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. (1995) (81)
Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene. (2007) (81)
Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype (2009) (80)
Methylation of the Cyclin A1 Promoter Correlates with Gene Silencing in Somatic Cell Lines, while Tissue-Specific Expression of Cyclin A1 Is Methylation Independent (2000) (80)
Gamma-interferon induces expression of the HLA-D antigens on normal and leukemic human myeloid cells. (1984) (80)
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray (2008) (80)
TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells (2002) (79)
Novel Therapeutic Approach: Ligands for PPARγ and Retinoid Receptors Induce Apoptosis in bcl-2-positive Human Breast Cancer Cells (2002) (79)
Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. (1996) (79)
Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells. (2008) (78)
Immunohistochemical analysis of p53 expression in malignant lymphomas. (1992) (78)
Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. (1999) (78)
Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL) (2002) (78)
HIV-1 Protease Inhibitor, Ritonavir (2004) (77)
Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions. (2000) (77)
Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia. (2017) (76)
Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. (2001) (75)
Expression of Retinoic Acid Receptor-β Sensitizes Prostate Cancer Cells to Growth Inhibition Mediated by Combinations of Retinoids and a 19-nor Hexafluoride Vitamin D3 Analog. (1998) (75)
Recombinant gibbon interleukin-3 acts synergistically with recombinant human G-CSF and GM-CSF in vitro. (1988) (75)
p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression (1988) (75)
Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1. (2003) (75)
Cell Cycle Alterations in the Blastoid Variant of Mantle Cell Lymphoma (MCL-BV) as Detected by Gene Expression Profiling of Mantle Cell Lymphoma (MCL) and MCL-BV (2003) (73)
Toward therapeutic intervention of cancer by vitamin D compounds. (1997) (73)
Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids. (1999) (73)
Regulation of manganese superoxide dismutase and other antioxidant genes in normal and leukemic hematopoietic cells and their relationship to cytotoxicity by tumor necrosis factor. (1993) (73)
Tumor necrosis factor: receptors on hematopoietic cells. (1987) (71)
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells (2008) (71)
ERCC5 is a novel biomarker of ovarian cancer prognosis. (2008) (71)
C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation (2005) (70)
Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas. (1995) (69)
Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues (2007) (69)
Cytokine messenger RNA stability is enhanced in tumor cells. (1991) (68)
Membrane differentiation in human myeloid cells: expression of unique profiles of cell surface glycoproteins in myeloid leukemic cell lines blocked at different stages of differentiation and maturation. (1981) (68)
Decreased expression of p33ING1 mRNA in lymphoid malignancies (1999) (68)
Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. (2004) (68)
Human preleukemia. (1980) (68)
Discovery of epigenetically silenced genes in acute myeloid leukemias (2007) (68)
Common deleted genes in the 5q− syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice (2007) (68)
Restoration of C/EBPα Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation* (2003) (67)
NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines (2006) (67)
Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro. (1986) (67)
1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia. (1994) (66)
Syndromes of acute nonlymphocytic leukemia. (1987) (66)
BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1 (2002) (66)
Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas. (1993) (65)
Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. (1996) (65)
Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid. (1997) (65)
1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. (2002) (65)
Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD) (2016) (65)
Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias. (2001) (64)
Vitamin D compounds: activity against microbes and cancer. (2006) (63)
Identification of Interaction Partners and Substrates of the Cyclin A1-CDK2 Complex* (2004) (63)
Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression. (1985) (63)
DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML. (2006) (62)
Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. (2000) (62)
Absence of HHV-8 in prostate and semen. (1996) (61)
Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. (1998) (61)
Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPbeta-deficient hematopoietic cells. (2008) (61)
Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma (2017) (60)
Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening. (2010) (60)
Alterations of CDKN2 (p16) in non‐small cell lung cancer (1995) (60)
C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice. (2012) (59)
Therapy-related myelodysplastic syndromes. (1992) (59)
Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. (1994) (59)
Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations. (2009) (59)
Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. (1996) (58)
Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. (2007) (58)
19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines. (1998) (58)
19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines. (1997) (57)
Identification of Transcriptional Activation and Repression Domains in Human CCAAT/Enhancer-binding Protein ε* (1998) (57)
Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia (2010) (57)
Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function. (2001) (57)
Proteasome inhibitor PS‐341 down‐regulates prostate‐specific antigen (PSA) and induces growth arrest and apoptosis of androgen‐dependent human prostate cancer LNCaP cells (2004) (57)
Chromosomal abnormalities and novel disease‐related regions in progression from Barrett's esophagus to esophageal adenocarcinoma (2009) (56)
19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. (1998) (56)
The PPARγ ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines (2004) (56)
Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes. (1997) (56)
Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors. (1998) (55)
Methylation of the p16INK4A gene in multiple myeloma (1998) (55)
The correlation pattern of acquired copy number changes in 164 ETV6/RUNX1-positive childhood acute lymphoblastic leukemias. (2010) (55)
HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells. (2000) (55)
Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. (1999) (54)
Oncogenes in multiple myeloma: point mutation of N-ras. (1990) (54)
C/EBP-β, C/EBP-δ, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies (2002) (54)
Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18 (2006) (53)
Myeloid cell lines: tools for studying differentiation of normal and abnormal hematopoietic cells. (1988) (53)
Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray. (2006) (52)
Vitamin D compounds in leukemia (2005) (52)
1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. (1988) (52)
Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors (2002) (51)
c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression. (1999) (51)
Cellular maturation in human preleukemia. (1978) (50)
Resveratrol, a Natural Product Derived from Grapes, Is a New Inducer of Differentiation in Human Myeloid Leukemias (2002) (50)
TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia (1997) (50)
CCAAT/Enhancer Binding Protein α (C/EBPα) and C/EBPα Myeloid Oncoproteins Induce Bcl-2 via Interaction of Their Basic Regions with Nuclear Factor-κB p50 (2005) (50)
1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. (1994) (50)
Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. (1999) (49)
Alterations of the p16 (MTS1) gene in testicular, ovarian, and endometrial malignancies. (1995) (49)
Mutant p53 proteins behave in a dominant, negative fashion in vivo. (1994) (49)
Highly active analogs of 1α,25-dihydroxyvitamin D3 that resist metabolism through C-24 oxidation and C-3 epimerization pathways (2001) (49)
Receptor-targeted quantum dots: fluorescent probes for brain tumor diagnosis. (2007) (49)
Allelotype analysis in the evolution of chronic myelocytic leukemia. (1997) (49)
Detailed deletion mapping of the long arm of chromosome 6 in adult T-cell leukemia. (1999) (49)
p21WAF1 mutations and human malignancies. (1997) (48)
Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505). (1999) (48)
Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor κB (2008) (48)
Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates macrophages to produce interleukin-1 and tumor necrosis factor mRNA and protein. (2007) (48)
Structural integrity of the cyclin‐dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias (1995) (48)
Regulation of levels of IL‐1 mRNA in human fibroblasts (1989) (47)
Allelic loss in the progression of myelodysplastic syndrome. (2000) (47)
Phenotypic and functional alterations of peripheral blood monocytes in neutrophil‐specific granule deficiency (2004) (47)
Myeloperoxidase (MPO) gene mutation in hereditary MPO deficiency. (1994) (47)
Preleukemia: one name, many meanings (2016) (47)
Mutations of the p53 gene are not detectable in human testicular tumors. (1994) (46)
Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridization. (2002) (46)
In Vivo Deficiency of Both C/EBPβ and C/EBPε Results in Highly Defective Myeloid Differentiation and Lack of Cytokine Response (2010) (46)
Macrophage functional maturation and cytokine production are impaired in C/EBP epsilon-deficient mice. (2002) (46)
Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells. (2007) (45)
Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays. (2003) (45)
Cloning of the cyclin A1 Genomic Structure and Characterization of the Promoter Region (1999) (45)
1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells (1991) (45)
Molecular genetic advances in chronic myelogenous leukemia. (1990) (45)
Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. (1992) (44)
Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia (2011) (44)
Erythropoiesis in preleukemia. (1978) (44)
Microsatellite instability during the progression of acute myelocytic leukaemia (1997) (43)
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. (2004) (43)
Altered Apoptosis Pathways in Mantle Cell Lymphoma (2004) (43)
Multiple mechanisms control the expression of granulocyte-macrophage colony-stimulating factor by human fibroblasts. (1989) (43)
Characterization of adenosine‐uridine‐rich RNA binding factors (1995) (42)
Effect of homoharringtonine on proliferation and differentiation of human leukemic cells in vitro. (1990) (42)
19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. (2005) (42)
Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. (2004) (42)
Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p (2003) (41)
Analysis of p53 transactivation through high-affinity binding sites. (1993) (41)
Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia. (2011) (41)
Tumor necrosis factor α: Posttranscriptional stabilization of WAF1 mRNA in p53‐deficient human leukemic cells (1996) (40)
The 16-Ene Vitamin D Analogs (1997) (40)
Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor. (1987) (40)
Chronic myelocytic leukemia: eosinophils involved in the malignant clone. (1980) (40)
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations. (2010) (40)
Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia/lymphoma. (2006) (40)
Preadipocytes stimulate breast cancer cell growth. (1998) (40)
Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas (2008) (40)
Blockade of MEK/ERK signaling enhances sunitinib-induced growth inhibition and apoptosis of leukemia cells possessing activating mutations of the FLT3 gene. (2008) (40)
Differential Sensitivities of Malignant and Normal Skin Cells to Nanosecond Pulsed Electric Fields (2011) (39)
Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells. (1994) (39)
p53 mutations and MDM-2 amplification in renal cell cancers. (1994) (39)
PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock. (2003) (39)
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia. (2009) (39)
Effects of phorbol ester on translocation and down-regulation of protein kinase C and phosphorylation of endogenous proteins in human acute myeloid leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a. (1987) (39)
Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array. (2009) (39)
Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase. (2008) (38)
Induction by Phorbol Esters of Macrophage Differentiation in Human Leukaemia Cell Lines does not Require Cell Division (1981) (38)
Analysis of Aurora B kinase in non-Hodgkin lymphoma (2009) (38)
Establishment of the acute myeloid leukemia cell line Kasumi‐6 from a patient with a dominant‐negative mutation in the DNA‐binding region of the C/EBPα gene (2003) (38)
Differential effects of various protein kinase C activators on protein phosphorylation in human acute myeloblastic leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a. (1987) (37)
Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo. (2010) (37)
Analysis of the CHK2 Gene in Lymphoid Malignancies (2001) (37)
In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cells. (1987) (37)
Modulation of Mr 53,000 protein with induction of differentiation of human neuroblastoma cells. (1988) (37)
Myelodysplastic syndromes (preleukemia). (1986) (37)
Integrity of the 1,25‐dihydroxyvitamin D3 receptor in bone, lung, and other cancers (1997) (37)
The p19INK4D Cyclin dependent kinase inhibitor gene is altered in osteosarcoma (1997) (37)
Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes. (2004) (37)
Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription. (1993) (37)
RARβ2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia (2004) (37)
Kaposi's sarcoma‐associated herpesvirus/human herpesvirus type 8 encephalitis in HIV‐positive and ‐negative individuals (1997) (37)
Infrequent microsatellite instability during the evolution of myelodysplastic syndrome to acute myelocytic leukemia. (1996) (37)
The aberrant fusion proteins PML-RARα and PLZF-RARα contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia (2000) (36)
Secondary myelodysplastic syndromes and leukemias. (1994) (36)
Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway (2006) (36)
Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions (2011) (36)
Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL) (1997) (36)
C/EBP-beta, C/EBP-delta, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies. (2002) (36)
9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro. (1993) (36)
p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines. (1996) (35)
Granulocyte-macrophage colony-stimulating factor: signals for its mRNA accumulation. (1989) (35)
Myelodysplastic syndrome. (2005) (35)
Studies of vitamin D (calciferol) and its analogs. 39. Arocalciferols: synthesis and biological evaluation of aromatic side-chain analogs of 1.alpha.,25-dihydroxyvitamin D3 (1991) (35)
Cloning of the Novel Human Myeloid-Cell-Speciﬁc C/EBP- e Transcription Factor (1997) (35)
Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia. (2006) (34)
Myeloperoxidase: Localization, Structure, and Function (1991) (34)
Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis. (2012) (34)
RWJ-241947 (MCC-555), A Unique Peroxisome Proliferator-Activated Receptor-γ Ligand with Antitumor Activity against Human Prostate Cancer in Vitro and in Beige/Nude/ X-Linked Immunodeficient Mice and Enhancement of Apoptosis in Myeloma Cells Induced by Arsenic Trioxide (2004) (34)
Identification of murine and human XCP1 genes as C/EBP-ε-dependent members of FIZZ/Resistin gene family (2004) (34)
Effects of long-term administration of vitamin D3 analogs to mice. (2000) (34)
Regional assignment of genes for human alpha-globin and phosphoglycollate phosphatase to the short arm of chromosome 16. (1981) (34)
6-trans-16-ene-Vitamin D 3 : A New Class of Potent Inhibitors of Proliferation of Prostate , Breast , and Myeloid Leukemic Cells 1 (1999) (33)
Methylation Analysis of Cell Cycle Control Genes in Adult T-Cell Leukemia/Lymphoma (2001) (33)
Dual PPARα/γ Ligand TZD18 Either Alone or in Combination with Imatinib Inhibits Proliferation and Induces Apoptosis of Human CML Cell Lines (2006) (33)
Differentiation therapy in myelodysplastic syndromes. (1996) (33)
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein a in myelodysplastic syndromes and acute myeloid leukemias (2002) (33)
Humoral modulation of human acute myelogenous leukemia cell growth in vitro. (1980) (33)
Novel therapeutic approach: organic arsenical (melarsoprol) alone or with all-trans -retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo (2000) (33)
Splenic Irradiation in Myelofibrosis: Effect on Circulating Myeloid Progenitor Cells (1979) (32)
Novel Gemini vitamin D3 analogs have potent antitumor activity (2008) (32)
The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARα and regulates differentiation of hematopoietic cells (2004) (32)
Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A (1997) (32)
Deregulated Intracellular Signaling by Mutated c-CBL in Myeloid Neoplasms (2010) (32)
RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation. (2007) (32)
Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia. (2003) (32)
25-Hydroxyvitamin D3 metabolism by human T-lymphotropic virus-transformed lymphocytes. (1987) (32)
PC-SPES inhibits colon cancer growth in vitro and in vivo. (2002) (32)
Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells. (2002) (32)
Molecular analysis of the INK4 family of genes in prostate carcinomas. (1997) (31)
Microsatellite instability and other molecular abnormalities in childhood acute lymphoblastic leukaemia (1997) (30)
H-Ferritin Is Preferentially Incorporated by Human Erythroid Cells through Transferrin Receptor 1 in a Threshold-Dependent Manner (2015) (30)
Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. (1999) (30)
The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells. (2002) (30)
Expression of Id2 and Id3 mRNA in human lymphocytes. (1995) (30)
Novel vitamin D3 analog (CB1093) when combined with paclitaxel and cisplatin inhibit growth of MCF-7 human breast cancer cells in vivo. (1998) (30)
24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation. (2001) (30)
INHIBITION OF THE CLONAL GROWTH OF HUMAN MYELOID LEUKEMIA CELLS (1982) (30)
Differentiation-inducing agents in the treatment of myelodysplastic syndromes. (1992) (30)
Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells (1996) (29)
Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy (2009) (29)
Modulation of interleukin-1 beta RNA in monocytic cells infected with human immunodeficiency virus-1. (1990) (29)
JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA) (2004) (29)
Novel CUX1 missense mutation in association with 7q− at leukemic transformation of MPN (2011) (29)
Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis. (2002) (29)
Recombinant human tumor necrosis factor alpha regulates c-myc expression in HL-60 cells at the level of transcription. (1987) (28)
Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes. (1989) (28)
Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-κB signal pathway (2007) (28)
Nanoelectropulse Intracellular Perturbation and Electropermeabilization Technology: Phospholipid Translocation, Calcium Bursts, Chromatin Rearrangement, Cardiomyocyte Activation, and Tumor Cell Sensitivity (2005) (28)
CCAAT/enhancer binding protein epsilon: changes in function upon phosphorylation by p38 MAP kinase. (2005) (27)
Chronic Myelocytic Leukaemia: a Pluripotent Haemopoietic Cell is Involved in the Malignant Clone (1981) (27)
Inhibition of MEK/ERK signaling synergistically potentiates histone deacetylase inhibitor-induced growth arrest, apoptosis and acetylation of histone H3 on p21waf1 promoter in acute myelogenous leukemia cell (2008) (27)
Analysis of p16INK4a and its interaction with CDK4. (1996) (27)
Microsatellite instability in adult T‐cell leukaemia (1998) (27)
TMEFF1 and brain tumors (2003) (27)
Study of differentiation of fresh myelogenous leukemic cells by compounds that induce a human promyelocytic leukemic line (HL-60) to differentiate. (1985) (27)
Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling. (2007) (27)
Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells (2006) (27)
Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. (1996) (27)
Is Kaposi's Sarcoma–Associated Herpesvirus Ubiquitous in Urogenital and Prostate Tissues? (1997) (26)
Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia. (2005) (26)
Characterization of a Myeloid Tyrosine Phosphatase, Lyp, and Its Role in the Bcr-Abl Signal Transduction Pathway* (2003) (26)
Specific binding of [3H]phorbol dibutyrate to phorbol diester-responsive and -resistant clones of a human myeloid leukemia (KG-1) line 1. (1983) (26)
Chronic myelogenous leukemia--new concepts (second of two parts). (1981) (26)
Ovarian Cancer: Loss of Heterozygosity Frequently Occurs in the ATM Gene, but Structural Alterations Do Not Occur in This Gene (1999) (25)
Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies. (1996) (25)
Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromes. (1997) (25)
Localization of p53 protein and human papillomavirus in anogenital squamous lesions: immunohistochemical and in situ hybridization studies in benign, dysplastic, and malignant epithelia. (1993) (25)
Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1α,25-dihydroxyvitamin D3 receptor (1990) (25)
Localization of the c-ets-2 transactivation domain (1993) (25)
Analysis of mutations of neurofibromatosis type 1 gene and N‐ras gene in acute myelogenous leukemia (1995) (25)
Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia (1999) (25)
Human myelogenous leukemia: enhanced clonal proliferation in the presence of phorbol diesters. (1981) (25)
Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. (1990) (25)
Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD18. (2006) (25)
Production of Interleukin-10 in the Cerebrospinal Fluid in Aseptic Meningitis of Children (1996) (25)
An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions (2015) (25)
Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog. (1998) (25)
Expression of retinoic acid receptor mRNA in hematopoietic cells. (1990) (25)
Arocalciferols: synthesis and biological evaluation of aromatic side-chain analogues of 1 alpha,25-dihydroxyvitamin D3(1a). (1991) (24)
Growth inhibition of DU-145 prostate cancer cells by a Bcl-2 antisense oligonucleotide is enhanced by N-(2-hydroxyphenyl)all-trans retinamide. (1998) (24)
Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor α/γ, in human breast cancer cells (2009) (24)
Use of conditioned media in cell culture can mask cytogenetic abnormalities in acute leukemia. (1990) (24)
Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB. (2008) (24)
Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi's sarcoma and their clinical follow-up. (1998) (24)
Chronic phase of ETV6‐ABL1 positive CML responds to imatinib (2008) (24)
Identification of neutrophil alkaline phosphatase‐inducing factor in cystic fluid of a human squamous cell carcinoma as granulocyte colony‐stimulating factor (1988) (24)
HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24. (2006) (24)
Human myeloid precursors forming colonies in diffusion chambers expresses the Ia-like antigen. (1979) (24)
CEBPD suppresses prolactin expression and prolactinoma cell proliferation. (2011) (23)
Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway. (2005) (23)
Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3. (1986) (23)
Action of granulocyte-macrophage colony-stimulating factors: studies using a human leukemia cell line. (1980) (23)
Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo. (2008) (23)
Evidence for a pretranslational defect in hereditary and acquired myeloperoxidase deficiency. (1989) (23)
The ATM gene and susceptibility to childhood T‐cell acute lymphoblastic leukaemia (1998) (23)
Allelotype analysis of adult T-cell leukemia. (1998) (23)
ATF4 differentially regulates transcriptional activation of myeloid‐specific genes by C/EBPε and C/EBPα (2007) (23)
Representational difference analysis using myeloid cells from C/EBPε deletional mice (2000) (23)
Ia antigen is a differentiation marker on human eosinophils. (1980) (23)
A Novel In-Frame Deletion in the Leucine Zipper Domain of C/EBPε Leads to Neutrophil-Specific Granule Deficiency (2015) (23)
1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells. (1991) (23)
Allelotype analysis in relapsed childhood acute lymphoblastic leukemia (2003) (22)
Effect of a novel vitamin D3 analog, EB1089, on G1 cell cycle regulatory proteins in HL-60 cells. (2000) (22)
Is Kaposi's sarcoma--associated herpesvirus ubiquitous in urogenital and prostate tissues? (1997) (22)
Mutations of the E2F4 gene in hematological malignancies having microsatellite instability. (2000) (22)
C/EBPα and the Vitamin D Receptor Cooperate in the Regulation of Cathelicidin in Lung Epithelial Cells (2015) (22)
Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance. (2015) (22)
Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo. (2012) (22)
Blockade of MEK signaling potentiates 5‐Aza‐2′‐deoxycytidine‐induced apoptosis and upregulation of p21waf1 in acute myelogenous leukemia cells (2009) (22)
Adaptor protein Lnk inhibits c‐Fms‐mediated macrophage function (2010) (22)
Mutations of p53 in Wilms' tumors. (1995) (22)
Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis. (2001) (22)
Poly(ADP‐ribosyl)ation of BRD7 by PARP1 confers resistance to DNA‐damaging chemotherapeutic agents (2019) (22)
Protein partners of C/EBPε (2004) (21)
Pattern of expression of HLA-DR and HLA-DQ antigens and mRNA in myeloid differentiation. (1987) (21)
Glucocorticoid sensitivity and receptors in cells of human myelogenous leukemia lines. (1980) (21)
BRCC3 mutations in myeloid neoplasms (2015) (21)
Advances in the treatment of acute myeloid leukemia: From chromosomal aberrations to biologically targeted therapy (2008) (21)
The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia. (2000) (21)
A Role for the PPARγ in Cancer Therapy (2008) (21)
The specific N-ras mutation in rat 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia. (1997) (21)
Identification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/Resistin gene family. (2004) (21)
Genome-Wide Mapping Of Copy Number Variations using SNP Arrays (2009) (21)
Evidence for 1,25-dihydroxyvitamin D3 production by cultured porcine alveolar macrophages (1991) (21)
The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. (2004) (20)
ZD6474 induces growth arrest and apoptosis of human leukemia cells, which is enhanced by concomitant use of a novel MEK inhibitor, AZD6244 (2007) (20)
Molecular analysis of myeloperoxidase deficiency shows heterogeneous patterns of the complete deficiency state manifested at the genomic, mRNA, and protein levels. (1993) (20)
Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts. (1996) (20)
DNA aneuploidy in morphologically normal colons from patients with colon cancer. (1995) (20)
CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. (2005) (19)
Transgenic mice overexpressing human copper/zinc-superoxide dismutase (Cu/Zn SOD) are not resistant to endotoxic shock. (1995) (19)
Effect of 1,25-dihydroxyvitamin D3 and its analogs on human immunodeficiency virus infection in monocytes/macrophages. (1993) (19)
Absence of microsatellite instability during the progression of chronic myelocytic leukemia (1997) (19)
Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. (1995) (19)
Metabolism of 1α,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells: In vitro biological activities of the natural metabolites of 1α,25-dihydroxyvitamin D3 produced in HL-60 cells (2001) (19)
Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells (2009) (19)
Amiloride potentiation of differentiation of human promyelocytic cell line HL-60. (1984) (19)
Synergistic inhibition of prostate cancer cell lines by a 19- nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid (1999) (19)
NEOPLASIA Loss of p 73 Gene Expression in Leukemias / Lymphomas Due to Hypermethylation (1999) (18)
A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders (2011) (18)
and Inducers of Differentiation of Human Breast Cancer Cell Lines (1995) (18)
Production of bone resorbing activity in poorly differentiated monocytic malignancy (1978) (18)
Modulation by retinoids and interferons of alkaline phosphatase activity in granulocytes induced by granulocyte colony-stimulating factor. (1989) (18)
20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. (1999) (18)
Human acute myeloid leukemia lines: models of leukemogenesis. (1986) (18)
RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia. (2004) (18)
Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells. (2009) (17)
Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia (2003) (17)
PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. (2003) (17)
Reprogramming of m6A epitranscriptome is crucial for shaping of transcriptome and proteome in response to hypoxia (2020) (17)
Genetic differences between Asian and Caucasian chronic lymphocytic leukemia (2013) (17)
Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemia (2002) (17)
Detection of Aberrant Gene Expression in CD34+ Hematopoietic Stem Cells from Patients with Agnogenic Myeloid Metaplasia Using Oligonucleotide Microarrays (2005) (17)
Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma. (2015) (17)
Expression of the adaptor protein Lnk in leukemia cells. (2009) (17)
Molecular analysis of the human myeloperoxidase promoter region. (2000) (17)
Molecular analysis of myeloperoxidase deficiency shows heterogeneous patterns of the complete deficiency state manifested at the genomic, mRNA, and protein levels (1993) (17)
Intractable diarrhoea of infancy caused by neutrophil specific granule deficiency and cured by stem cell transplantation (2006) (16)
Allelotype analysis of the myelodysplastic syndrome (2000) (16)
Is immunoreactivity for p53 useful in distinguishing benign from malignant effusions? Localization of p53 gene product in benign mesothelial and adenocarcinoma cells. (1994) (16)
Molecular Biology of Thyroid Cancer (2012) (16)
p27/Kipl Mutation Found in Breast Cancer1 (1996) (16)
Nuclear delivery of p53 C-terminal peptides into cancer cells using scFv fragments of a monoclonal antibody that penetrates living cells. (2003) (16)
Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome. (2006) (16)
NADE (p75NTR-associated cell death executor) suppresses cellular growth in vivo. (2003) (16)
A mouse model for vitamin D-induced human cathelicidin antimicrobial peptide gene expression (2019) (15)
Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RARα-altered sublines of HL-60 (1997) (15)
Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow. (1980) (15)
p53 in lymphomas of mucosal-associated lymphoid tissues. (1996) (15)
Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes. (2001) (15)
PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells. (2003) (15)
p 53 in Hematologic Malignancies (2002) (15)
1,25-Dihydroxyvitamin D 3 -induced Differentiation in a Human Promyelocytic Leukemia Cell Line (HL-60) : Receptor-mediated Maturation to Macrophage-like Cells (2002) (15)
C/EBPε −/− mice: increased rate of myeloid proliferation and apoptosis (2001) (15)
Methylation of the MLH1 gene in hematological malignancies. (2005) (14)
Identification of a new GLC1A mutation in a sporadic, primary open-angle glaucoma in Japan. (2003) (14)
C/EBP-ε: Chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia (1997) (14)
C/EBPepsilon -/- mice: increased rate of myeloid proliferation and apoptosis. (2001) (14)
Representational difference analysis using myeloid cells from C/EBP epsilon deletional mice. (2000) (14)
Tumor necrosis factor alpha: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. (1996) (13)
Adaptor Protein Lnk Inhibits C-Fms Mediated Macrophage Function (2008) (13)
A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RARalpha-mediated signals in myeloid leukemic cells. (1998) (13)
Rhabdomyolysis as a complication of 5-azacytidine. (1978) (13)
ATM‐Dependent Recruitment of BRD7 is required for Transcriptional Repression and DNA Repair at DNA Breaks Flanking Transcriptional Active Regions (2020) (13)
Frameshift mutations in caspase-5 and other target genes in leukemia and lymphoma cell lines having microsatellite instability. (2003) (13)
HIV-1 Protease Inhibitor , Ritonavir : A Potent Inhibitor of CYP 3 A 4 , Enhanced the Anticancer Effects of Docetaxel in Androgen-Independent Prostate Cancer Cells In vitro and In vivo (2004) (13)
Hematopoietic progenitor cells of transgenic mice with increased copper/zinc‐superoxide dismutase activity are resistant to tumor necrosis factor (1994) (13)
Production of 1 alpha,25-dihydroxyvitamin D3 by hematopoietic cells. (1990) (13)
Cytostatic effect of TNFα on cancer cells is independent of p21WAF1 (1997) (13)
Important features of myelodysplastic syndrome (2002) (13)
ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha. (2007) (13)
Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways. (2006) (13)
Multiple myeloma presenting as ascites. (1977) (12)
Chronic myelogenous leukemia--new concepts (first of two parts). (1981) (12)
Copy number analysis identifies tumor suppressive lncRNAs in human osteosarcoma. (2017) (12)
Immunotherapy against murine leukemia (1998) (12)
An interferon-γ activation sequence mediates the transcriptional regulation of the IgG Fc receptor type IC gene by interferon-γ (1995) (12)
Structural and Functional Studies of CCAAT/Enhancer-binding Protein ε* (2001) (12)
Stable methylation patterns of MYC and other genes regulated during terminal myeloid differentiation. (1991) (12)
Double minute chromosomes containing MYB gene and NUP214-ABL1 fusion gene in T-cell leukemia detected by single nucleotide polymorphism DNA microarray and fluorescence in situ hybridization. (2009) (12)
Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms (2010) (12)
Is there a role for differentiating therapy in non-APL AML? (2010) (12)
Co-infection of HHV-6 and HHV-8 is rare in primary effusion lymphoma. (2000) (12)
Amphotericin inhibition of hematopoiesis in vitro (1977) (12)
Structural and functional studies of CCAAT/enhancer-binding protein epsilon. (2001) (12)
Homozygous Deletions of the p 15 ( MTS 2 ) and p 16 ( CDKN 2 / MTS 1 ) Genes in Adult T-cell Leukemia (2000) (12)
Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow. (2005) (11)
Germline mutation of the p27/Kip1 gene in childhood acute lymphoblastic leukemia (2002) (11)
Per2 Is a C/EBP Target Gene Implicated in Myeloid Leukemia (2009) (11)
Analysis of c-kit gene integrity in aplastic anemia. (1996) (11)
Protein partners of C/EBPepsilon. (2004) (11)
C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia. (1997) (11)
mdm‐2 Oncogene Expression in Non‐Hodgkin's Lymphomas (1996) (10)
20-Epi-vitamin D3 analogs. Potent modulators of proliferation and differentiation of breast cancer cell lines in vitro. (1996) (10)
Vitamin D analogs, leukemia and WAF1. (1998) (10)
Mutations in the Retinoblastoma-related Gene RB2 / p130 in Adult T-cell Leukaemia/Lymphoma (2003) (10)
The 16-Ene Vitamin D Analogues (1997) (10)
Responsiveness of a human myelogenous leukemia cell line (KG-1) to humoral factors in vivo. (1980) (10)
Tumor Cell Differentiation (1987) (10)
An interferon-gamma activation sequence mediates the transcriptional regulation of the IgG Fc receptor type IC gene by interferon-gamma. (1995) (9)
The molecular biology of differentiation and proliferation using human myelogenous leukemia cells (1986) (9)
Study of Differentiation and Proliferation of Leukemic Cells Using Myeloid Leukemia Cell Lines (1985) (9)
Antigens present on human myeloid leukemia cell lines. (1980) (9)
Effects of harringtonine in combination with acivicin, adriamycin, L-asparaginase, cytosine arabinoside, dexamethasone, fluorouracil or methotrexate on human acute myelogenous leukemia cell line KG-1 (2004) (9)
Mutational analysis of the hMSH2 gene in a wide variety of tumors. (1997) (9)
Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis. (2012) (9)
Successive increases in human cyclin A1 promoter activity during spermatogenesis in transgenic mice. (2003) (9)
Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib. (2009) (9)
Translocon‐associated protein α transcripts are induced by granulocyte‐macrophage colony‐stimulating factor and exhibit complex alternative polyadenylation (1999) (9)
Vitamin D: myeloid differentiation and proliferation. (1985) (9)
DPC 4/SMAD 4 in non-pancreatic tumors with frequent LOH 18q21 and in hematological malignancies. (1997) (9)
5-fluorocytosine: inhibition of hematopoiesis in vitro and reversal of inhibition by uracil. (1979) (9)
Do cancer cells selectively mutate HFE to increase their intracellular iron? (2005) (9)
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes (2020) (9)
Ninth Annual Sapporo Cancer Seminar Cell Differentiation and Cancer Control (1990) (9)
Somatic cell hybrid analyses of hematopoietic differentiation (1981) (8)
Myelodysplastic syndromes. (1996) (8)
D-factor: modulation of expression in fibroblasts. (1991) (8)
Kawabata, H. et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J. Biol. Chem. 274, 20826-20832 (1999) (8)
PC-SPES down-regulates COX-2 via inhibition of NF-κB and C/EBPβ in non-small cell lung cancer cells (2006) (8)
HHV‐8 (KSHV) does not establish latency in prostate cancer cell lines (1997) (8)
Establishment of a novel human B‐cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes (1997) (8)
Deficiency of myeloperoxidase and abnormal chromosome 1 occurs in variant (HL60) promyelocytes. (1986) (8)
C/EBPα and C/EBPα Myeloid Oncoproteins Induce Bcl-2 Via Interaction of Their Basic Regions with NF-κB p50. (2005) (8)
Expression of Bactericidal/Permeability-Increasing Protein Requires C/EBPɛ (2007) (8)
Longitudinal inhibition of PI 3 K / Akt / mTOR signaling by LY 294002 and rapamycin induces growth arrest of adult T-cell leukemia cells (2006) (7)
Cyclin-dependent kinase inhibitors in human neoplasms. (1997) (7)
SRSF2 is Mutated in 47.2% (77/163) of Chronic Myelomonocytic Leukemia (CMML) and Prognostically Favorable in Cases with Concomitant RUNX1 mutations (2011) (7)
y-Interferon induces expression of the HLA-D antigens on normal and leukemic human myeloid cells ( major histocompatibility complex class II antigens ) (7)
Somatic cell hybrid analyses of hematopoietic differentiation. (1981) (7)
Retrospective analysis of ras gene activation in myeloid leukemic cells. (1990) (7)
Tumor necrosis factor stimulates Na+/H+ antiporter in human fibroblasts: dissociation between intracellular alkalinization and cytokine mRNA accumulation. (1992) (6)
PC-SPES down-regulates COX-2 via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells. (2006) (6)
Differentiation of human acute myelogenous leukemia cells: therapeutic possibilities. (1987) (6)
C/EBPε ΔRS derived from a neutrophil-specific granule deficiency patient interacts with HDAC1 and its dysfunction is restored by trichostatin A. (2019) (6)
Differentiation therapy. (1992) (6)
Absence of R24C Mutation of the CDK4 Gene in Leukemias and Solid Tumors (2003) (6)
Specific interaction between adenoviral 55-kDa E1B protein and in vivo produced p53 fusion proteins. (1993) (6)
The effect of retinoids on haemopoiesis--clinical and laboratory studies. (1985) (6)
Synthesis and biological activities of the two C(23) epimers of 1α,23,25-trihydroxy-24-oxo-19-nor-vitamin D3: novel analogs of 1α,23(S),25-trihydroxy-24-oxo-vitamin D3, a natural metabolite of 1α,25-dihydroxyvitamin D3 (2000) (5)
Methylenetetrahydrofolate reductase genotype does not play a role in adult T-cell leukemia/lymphoma pathogenesis among human T-lymphotrophic virus type 1 carriers. (2004) (5)
Tumor Cell Differentiation: Biology and Pharmacology (1987) (5)
Expression of hematopoietic growth factor RNAs in human mesenchymal cells from various organs. (1991) (5)
Allelic loss during progression of follicular lymphoma. (2004) (5)
p 53 Mutations in Human Lung Tumors 1 (2006) (4)
Myeloid colony-forming cell kinetics in man. (1980) (4)
Genome-Wide Analysis of MDS/MPD Disclosed Frequent Homozygous C-Cbl mutations Tightly Associated with 11q-UPD (2008) (4)
is critical for the development of a diverse primary B cell repertoire. (2010) (4)
Granulocyte-Macrophage Colony-stimulating Factor Sensitive and Receptor-mediated Regulation by 1 , 25-Dihydroxyvitamin D 3 in Normal Human Peripheral Blood Lymphocytes (2013) (4)
Leukaemic Transformation of Philadelphia-chromosome-negative Myeloproliferative Neoplasms — A Review of the Molecular Background (2011) (4)
CXCR 4 expression is associated with survival in familial chronic lymphocytic leukemia , but CD 38 expression (2002) (4)
Cytostatic effect of TNFalpha on cancer cells is independent of p21WAF1. (1997) (4)
Vitamin D compounds and analogs: effects on normal and abnormal Hematopoiesis. (1997) (4)
Growth inhibition and apoptosis in human Philadelphia chromosome – positive lymphoblastic leukemia cell lines by treatment with the dual PPAR / ligand TZD 18 (2006) (4)
with Human Immunodeficiency Virus-1 (1990) (4)
Therapy-Related Acute Myelogenous Leukemia (2013) (4)
Molecular analysis of INK4 genes in breast carcinomas. (1997) (4)
Mutational Spectrum Analysis of Interesting Correlation and Interrelationship Between RNA Splicing Pathway and Commonly Targeted Genes in Myelodysplastic Syndrome (2011) (4)
DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein ε (C/EBPε) gene (2001) (3)
ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells. (2006) (3)
ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS (2014) (3)
Roles of transferrin receptors in erythropoiesis. (2016) (3)
DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein epsilon (C/EBPepsilon) gene. (2001) (3)
Mantle Cell Lymphoma: SAHA Blocks Akt/mTOR Pathway and Reduces Cyclin D1 Protein Levels by Affecting Translation. (2004) (3)
Therapy-related myelodysplastic syndromes. (1992) (3)
Effect of Retinoids on Normal and Abnormal Hematopoiesis (1983) (3)
Herpesvirus 8 Inclusions in Primary Effusion Lymphoma (2009) (3)
Hidden Abnormalities and Novel Classification of t(15;17) APL Based on Genomic Alterations. (2007) (3)
Infrequent Alterations of the RARa Gene in Acute Myelogenous Leukemias , Retinoic Acid-Resistant Acute Promyelocytic Leukemias , Myelodysplastic Syndromes , and Cell Lines (2002) (3)
Decreased expression of p33ING1 mRNA in lymphoid malignancies (2000) (3)
Molecular analysis of the secretory phospholipase A2 gene, a candidate of Mom1 gene, in neuroblastomas. (1997) (2)
Colony Stimulating Factors: Regulation of Production (1992) (2)
In Vivo Deficiency of Both Transcription Factors, C/EBPbeta and C/EBPepsilon, Results in Lack of Cytokine Response and a High Susceptibility for Overwhelming Infections. (2009) (2)
Induction of granulocyte differentiation in a human leukemia cell line does not require cell division. (1986) (2)
Dominant Negative Form of PAX5 Is Generated by Multimerization of Its DNA Binding Domain (2010) (2)
Effects of long-term administration of vitamin D 3 analogs to mice (2000) (2)
Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults (2021) (2)
Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors (2018) (2)
375 HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer cells in conjunction with blockade of androgen receptor, STAT3, and AKT signaling (2004) (2)
CHAPTER 27 – Differentiation Induction in Leukemia and Lymphoma (2006) (2)
Frequent Loss of Heterozygosity on Chromosomes 6q, 9p, 11q or 12p in Childhood Acute Lymphoblastic Leukemia (1998) (2)
Adaptor Protein LNK Binds to and Is Phosphorylated by JAK3 and May Serve as a Scaffold for JAK3 Autophosphorylation In the Absence of An Appropriate Cytokine Receptor (2010) (2)
leukemia / lymphoma : correlation with clinical course Comparative genomic hybridization analysis in adult T-cell (2001) (2)
CCAAT / enhancer binding protein : changes in function upon phosphorylation by p 38 MAP kinase (2005) (2)
Rearrangement and expression of beta-T-cell receptor and immunoglobulin genes in established Ph1 chronic myelogenous leukemia cell lines. (1989) (2)
Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR−/− Mice (2014) (1)
Anticancer Activity and Induction of Multinucleation in Hematologic Cell Lines Mediated by Ganoderma Lucidum . (2004) (1)
Interaction of 1,25 Dihydroxyvitamin D3 with Normal and Abnormal Hematopoiesis (1987) (1)
PHAGOCYTES Myeloid Transcription Factor C / EBP e Is Involved in the Positive Regulation of Lactoferrin Gene Expression in Neutrophils (1999) (1)
The Anti-Tumor Effects of SU11248, a Class III Receptor Tyrosine Kinase Inhibitor, Against a Variety of Human Hematological Malignancies. (2005) (1)
Numerous Genomic Abnormalities in AML with Normal Karyotype. (2007) (1)
Hormonal responsiveness of two human acute myelogenous leukemia cell lines (1979) (1)
Differential Effects on Leukemic Cell Growth, Differentiation, and Intestinal Calcium Absorption1 (1990) (1)
Synthesis and biological activities of the two C(23) epimers of 1alpha,23,25-trihydroxy-24-oxo-19-nor-vitamin D(3): novel analogs of 1alpha,23(S),25-trihydroxy-24-oxo-vitamin D(3), a natural metabolite of 1alpha,25-dihydroxyvitamin D(3). (2000) (1)
Abstract 2147: Molecular allelokaryotyping to identify mechanism of development of Asian chronic lymphocytic leukemia (2010) (1)
Comparative analysis of genes regulated by PML/RAR (cid:1) and PLZF/RAR (cid:1) in response to retinoic acid using oligonucleotide arrays (2003) (1)
Functional Analysis of SRSF2 Mutations in Myelodysplastic Syndromes and Related Disorders (2011) (1)
T-antigen of sv40 blocks p53 transactivation but not p53 specific binding to DNA. (1994) (1)
Scutellaria Baicalensis, a Herbal Medicine: Antitumor Activity Against Acute Lymphocytic Leukemia, Lymphoma and Myeloma in Vitro. (2004) (1)
Chromatin and DNA Methylation Changes of the Human Myeloperoxidase Gene During Myeloid Differentiation (1990) (1)
myeloproliferative neoplasms negative - leukemic transformation of Philadelphia chromosome Prevalence and prognostic impact of allelic imbalances associated with (2011) (1)
Modulation of hematopoiesis by 1 25 dihydroxyvitamin d 3 (1986) (1)
The Human Cathelicidin Antimicrobial Peptide (CAMP) Gene Is a Direct Target of the Vitamin D Receptor and Is Strongly Upregulated in Myeloid Cells by 1,25(OH)2D3 Treatment. (2004) (1)
Myelodysplastic Syndromes: Molecular mechanisms and gene expression patterns in myelodysplastic syndromes (2005) (1)
Mutational analysis of the Hel-N1 gene in childhood acute lymphoblastic leukemia with LOH at 9p21 (1999) (1)
Adaptor Protein Lnk Negatively Regulates Bcr-Abl-Induced Cell Proliferation through Inhibition of the Stat5 Signaling Pathway. (2010) (1)
AROCALCIFEROLS: A NEW CLASS OF SIDE-CHAIN ANALOGS OF l,25(OH)2D3 (1991) (1)
leukemia identifies heterogeneous secondary genomic alterations SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid (2011) (1)
BCOR Is Involved in Myeloid Cell Growth Control by Regulating Hox Genes (2012) (1)
Welcome to the era of interconnecting pathways (2001) (1)
Chapter 88 – Hematological Malignancy (2011) (1)
Adaptor Protein Lnk Binds to PDGFRA, PDGFRB and FIP1L1-PDGFRA, but Not to the TEL-PDGFRB Fusion Protein. (2007) (1)
STRUCTURE-FUNCTION RELATIONSHIPS IN THE VITAMIN D ENDOCRINE SYSTEM FOR l,25(OH)2D3 ANALOGS (1991) (1)
Expression of Circadian Core Clock Gene Per2 Is Markedly Down-Regulated in Diffuse Large B-Cell Lymphoma (2008) (1)
Nanoelectropulse therapy for cancer: In vitro and in vivo analysis. (2006) (0)
Abstract 4602: Recurrent pathway mutations of multiple components of cohesin complex in myeloid neoplasms. (2013) (0)
AntitumorActivity of Suberoylanilide Hydroxamic Acid against Thyroid Cancer Cell Lines In vitro and In vivo (2006) (0)
Analysis of Aurora B Kinase in Non-Hodgkin’s Lymphoma. (2008) (0)
Marked Effect of the Combination of a Novel Vitamin D3 Analog, KH1060, and 9-cis-RA on Inhibition of Clonal Growth, Decreases of bcl-2 Level and Induction of Apoptosis in HL-60 Cells (1997) (0)
Deletion in Childhood Acute Lymphoblastic Leukemia Chromosome 6 : Identification of Two Distinct Regions of Frequent Loss of Heterozygosity on the Long Arm of Updated (2006) (0)
Identification of novel epigenetically silenced tumor suppressor genes in myeloid disorders (2004) (0)
Potent tumoricidal effects of a human cytotoxic T-cell line (TALL-104) against prostate cancer. (1997) (0)
Identification of Novel Secreted Molecules of Prostate Cancer (1999) (0)
METABOLISM IN VITRO OF 25-HYDROXYVITAMIN D3 BY CULTURED PORCINE ALVEOLAR MACROPHAGES. (1988) (0)
ASXL2 Is Recurrently Mutated in t(8;21) AML and Regulates Hematopoietic Development (2016) (0)
Abstract 4849: Profiling of multiple gene mutations in myelodysplastic syndromes using high-throughput resequenceing combined with barcode labeling (2011) (0)
0168: Whole Genome Copy Number Analysis of Advanced Ovarian Cancer Identifies Patterns Associated with Prolonged Survival (2006) (0)
Peroxisome Proliferator-activated Receptor and Cancers 1 (2003) (0)
High Density SNP Array Analysis of Tyrosine Kinase Inhibitor (TKI) Resistant Chronic Myeloid Leukemia (CML) Shows Secondary Genomic Alterations (2008) (0)
Induction of Immunity Against Leukemia (1996) (0)
Vitamin D3-Mediated Regulation of the Antimicrobial Peptides CAMP and DEFB4 Is Evolutionarily Important for Innate Immunity in Humans and Primates. (2005) (0)
Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells. (2001) (0)
Negative Feedback Signaling Enables Leukemic Transformation by Oncogenic Tyrosine Kinases (2012) (0)
Advances in Brief Mutational Effects on the pl 6 INK 4 a Tumor Suppressor Protein 1 (2006) (0)
Identification of Putative New Tumor Suppressor Genes in Highly Purified CD34+ Bone Marrow Cells from Patients with Myelodysplastic Syndromes. (2004) (0)
Colony-stimulating factors: clinical promises. (1989) (0)
Abstract 245: An oncogenic role forCCAAT/enhancer binding protein betain non-small cell lung cancer (2010) (0)
Hidden abnormalities and novel disease-related genomic changes during development of esophageal adenocarcinomas (2008) (0)
Mutation Found in Breast Cancer 1 (2006) (0)
Identification of Marker Genes That Discriminate between Different Myeloproliferative Disorders and Normal Individuals Including RUNX3 (AML2). (2005) (0)
Profiling of Multiple Gene Mutations In Myelodysplastic Syndromes Using High-Throughput Resequenceing Combined with Barcode Labeling (2010) (0)
Granulocyte-macrophage colony-stimulating factor (1992) (0)
Abstract 2348: Cyr61 and FOXOA1 are inversely regulated in IGF-1 mediated breast cancer cells (2011) (0)
HEMATOPOIESIS 1 , 25-Dihydroxyvitamin D 3 Induces Differentiation of a Retinoic Acid – Resistant Acute Promyelocytic Leukemia (1999) (0)
B-Lymphoid Transcription Factors Restrict Glycolytic Energy Supply for Oncogenic Signaling (2015) (0)
Functional Assessment in Myelodysplasia- Numerical Recovery of Neutrophils May Be Insufficient for Adequate Neutrophil Function. (2004) (0)
Adaptor Protein Lnk Negatively Regulates Mutant MPL and JAK2 Alleles Associated with Myeloproliferative Disorders (2007) (0)
Proliferation and Differentiation In Vitro Effects of Novel RAR- and RXR-Selective Retinoids on Myeloid Leukemic (2010) (0)
RTP801 Is a Novel Retinoic Acid Responsive Gene Possibly Involved in Myeloid Differentiation. (2005) (0)
Title Single nucleotide polymorphism genomic arrays analysis of t ( 8 ; 21 ) acutemyeloid leukemia cells (2017) (0)
Clinical Trial of Paricalcitol in Myelodysplastic Syndrome. (2004) (0)
Genetic Profiling of Adult Acute Lymphoblastic Leukemia Cells by Single Nucleotide Polymorphism Oligonucleotide Microarray. (2007) (0)
INTERACTION BETWEEN THE HEMATOPOIETIC SYSTEM AND THE VITAMIN D ENDOCRINE SYSTEM (1988) (0)
Cells of Proliferation of Prostate , Breast , and Myeloid Leukemic : A New Class of Potent Inhibitors 3-16-ene-Vitamin D trans 5 , 6-Updated (1999) (0)
Myeloid haemopoietic cells of patients with chronic granulomatous disease are relatively resistant to TNF (1994) (0)
BRIEF COMMUNICATION Absence of microsatellite instability during the progression of chronic myelocytic leukemia (1997) (0)
Myelogenous Leukemia Lines Glucocorticoid Sensitivity and Receptors in Cells of Human (2013) (0)
HIV-1 Protease Inhibitor Ritonavir Potentiates the Effect of 1,25-Dihydroxyvitamin D 3 to Induce Growth Arrest and Differentiation of Human Myeloid Leukemia Cells Via Inhibition of CYP24. (2004) (0)
The Plasma Cell Transcription Factor XBP1 is Required To Mitigate The Unfolded Protein Response In Ph+ ALL (2013) (0)
promyelocytic leukemia (APL) based on genomic alterations Hidden abnormalities and novel classification of t(15;17) acute (2013) (0)
HumoralModulationof Human Acute MyelogenousLeukemia Cell Growth in (1980) (0)
bone mobilization differentiation with little effect on either intestinal calcium absorption or Novel vitamin D analogs that modulate leukemic cell growth and (2011) (0)
Utility of Quantum Dots for Labeling and Tracking Leukemic Cell Lines, Human Bone Marrow and CD 34+ Umbilical Cord Blood. (2005) (0)
Novel Deuterated Gemini-Vitamin D3 Analogs Have Potent Antitumor Activity. (2007) (0)
Dominant-Negative Impact of PAX5/TEL on Downstream Targets of PAX5 and Essential Pre-B Cell Receptor Genes (2010) (0)
Older Patients with Normal Cytogenetics AML Have a Higher Rate of Genomic Changes Compared to Young Patients as Determined by SNP Chip Analysis (2010) (0)
Myeloid Differentiation Mediated Through New Potent Retinoids and Vitamin D3 Analogs (1996) (0)
Single nucleotide polymorphism in MDM2 is associated with sporadic endometrial cancer risk. (2006) (0)
Vitamin-D Analogs : A New Class of Potent Inhibitors of Proliferation and Inducers of Differentiation of Human Myeloid Leukemia Cell Lines (1998) (0)
Abstract 2450: Mutational profiling of MLL-PTD acute myeloid leukemia (2017) (0)
CCAAT/Enhancer Binding Protein Epsilon Mediates Nicotinamide-Enhanced Clearance of Staphylococcus Aureus Infection (2010) (0)
Alterations of the ~ 2 7 ~ ' ' ' Gene in Non-Hodgkin ' s Lymphomas and Adult T-Cell Leukemia / Lymphoma (2002) (0)
Differentiation inducers and their potential use in the treatment of acute myelogenous leukaemia (1992) (0)
Deletions of the Cyclin-Dependent Kinase Inhibitor Genes p 161 NK 4 * and ~ 1 5 ' ~ ~ ~ ~ in Non-Hodgkin ' s Lymphomas (2000) (0)
Genetic Differences Between BRCA-Associated and Sporadic Ovarian Cancer DNA (2007) (0)
Vitamin D and Hematologic Malignancies (2011) (0)
Novel dual PPARα/γ ligands, TZD18 and compound 48, as growth inhibitors of CML cell lines (2007) (0)
48 Next-generation sequencing technology combined with multiplexed barcoded samples of myelodysplastic syndromes reveals an abundance of target gene mutations (2011) (0)
Immunoregulatory and Prodifferentiating Effects of 1,25-Dihydroxyvitamin D3 in Human Mononuclear Cells (2020) (0)
Vitamin D3 and Retinoid-Mediated Inhibition of Leukemic Cells (1998) (0)
Homozygous Deletion of the p16 Gene in Childhood Acute Lymphoblastic Leukemia (1997) (0)
Rare Mutations of the PIK3CA Gene in Hematologic Malignancies. (2004) (0)
C/EBPα and C/EBPα Myeloid Oncoproteins Inhibit Apoptosis and Induce Bcl-2 Via DNA-Binding Dependent and Independent Mechanisms. (2004) (0)
WAF 1 / CIP 1 Expression of p 21 Resistant Acute Promyelocytic Leukemia Cell Line ( UF-1 ) Associated With − Induces Differentiation of a Retinoic Acid 31 , 25-Dihydroxyvitamin D (1999) (0)
Structural and Functional Studies of C / EBP ε (2001) (0)
1,25(OH)2VITAMIN D3 ANALOGS: COMPARISON OF 1,25(OH)2D3 RECEPTOR LIGAND SPECIFICITY AND BIOLOGICAL ACTIVITY IN THE CHICK AND HUMAN PROMYELOCYTE (HL-60) CELLS. (1988) (0)
Neutrophil-Specific Granule Deficiency Leads to ε Zipper Domain of C / EBP A Novel In-Frame Deletion in the Leucine (2015) (0)
Koeffler therapeutic implications Induction of differentiation of human acute myelogenous leukemia cells (2005) (0)
Blockade of mTOR Signaling Potentiates the Ability of Histone Deacetylase Inhibitor to Induce Growth Arrest and Differentiation of Acute Myelogenous Leukemia Cells. (2008) (0)
CEBPalpha and a Critical Circadian Clock Downstream Target Gene, PER2 , Are Highly Dysregulated in Diffuse Large B-Cell Lymphoma. (2009) (0)
Differentiation therapy for myelodysplastic syndrome. (2002) (0)
PAX5/TEL Exhibits a Dominant-Negative Role by Inhibiting the Expression of Genes Involved in BCR Signalling and Suppressing the Binding of Wild Type PAX5 to Its Direct Target Gene CD79A (mb-1) in a human Pre-B ALL Cell Line. (2009) (0)
ChIP-on-Chip Analysis Using Dominant Negative Form of PAX5 Fusion Gene Revealed Genes Associated with Tumorigenesis Were Directly Regulated by PAX5 in a Human B Cell Line, NALM6 (2008) (0)
Cucurbitacin D Upregulates Fetal Hemoglobin Expression in K562 Cells and Human Erythroid Progenitors. (2007) (0)
A Novel 2 Amino Acids Deletion in the Leucine Zipper Domain of C/EBPε Leads to Neutrophil-Specific Granule Deficiency (SGD) (2014) (0)
Carriers Leukemia / Lymphoma in Human T-lymphotropic Virus Type 1 Increased Susceptibility to Development of Adult T-Cell Polymorphism Associated with α Tumor Necrosis Factor (2001) (0)
Hybrid eosinophilic-basophilic acute myeloid leukaemia diagnosed by electron microscopy (2007) (0)
O1-18-3EXOME SEQUENCING AND SNP ARRAY REVEAL EPIGENOME MODIFIER DEFECTS IN NASOPHARYNGEAL CARCINOMA (2014) (0)
Vitamin D3-Mediated Regulation of Antimicrobial Peptide Expression by Ancient Transposable Elements Conserved Only in Humans and Primates. (2006) (0)
RAPID COMMUNICATION Localization of Kaposi’s Sarcoma – Associated Herpesvirus in Bone Marrow Biopsy Samples From Patients With Multiple Myeloma (1997) (0)
chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new genes. (2007) (0)
Abstract 4670: TIP60 regulates alternative splicing of Integrin subunit alpha 6 (2020) (0)
Identification of Epigenetically Silenced Tumor Suppressor Genes in Myeloid Disorders Leads to the Identification of α-Catenin as a Target Gene in 5q- Syndrome. (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With H. Phillip Koeffler?

H. Phillip Koeffler is affiliated with the following schools:

H. Phillip Koeffler's Academic­Influence.com Rankings

Why Is H. Phillip Koeffler Influential?

H. Phillip Koeffler's Published Works

Published Works

What Schools Are Affiliated With H. Phillip Koeffler?

H. Phillip Koeffler's AcademicInfluence.com Rankings